Skip to content
GLP-1 Desk
Menu
Dispatch #163

24hrDOC

24hrDOC is a fast cash-pay telehealth service that prescribes compounded GLP-1 medications for weight loss, including once-weekly semaglutide injections, oral semaglutide tablets, and tirzepatide.

Visit 24hrDOCAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$149/mo (2 mg dose, compounded)
Tirzepatide
$239/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Weigh 24hrDOC against the full ranked field on the best semaglutide providers board, or line it up against its closest alternatives. Or go one-on-one: 24hrDOC vs CoreAge Rx. Because 24hrDOC dispenses compounded medication, it’s worth understanding whether compounded GLP-1 is legit and safe.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency86/100
State access24/100
Molecule range77/100
Onboarding speed70/100
Support responsiveness82/100
Licensing & trust68/100

What the Desk likes

  • Low compounded semaglutide price, around 149 per month
  • Fast model: 10-minute assessment, Rx within 45 minutes
  • Injectable and oral semaglutide plus tirzepatide options
  • 24/7 availability with unlimited provider messaging

Where points come off

  • Compounded only, not FDA-approved branded GLP-1s
  • Self-pay only, no insurance accepted
  • States served not disclosed on the site
  • Fast-prescribing model offers less in-depth clinical workup

The Desk's briefing — C

Best for: Readers who want cash-pay patients wanting fast, low-cost compounded semaglutide or tirzepatide.

24hrDOC ranks #163 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (18)

Pricing and verification reflect 24hrDOC's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on 24hrDOC's site. Not medical advice; see our disclosure.

← Back to The Desk